0001213900-23-088896.txt : 20231120
0001213900-23-088896.hdr.sgml : 20231120
20231120201416
ACCESSION NUMBER: 0001213900-23-088896
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIGGANS THOMAS G
CENTRAL INDEX KEY: 0001208907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 231424211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0508
4
2023-11-16
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001208907
WIGGANS THOMAS G
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE 102
REDWOOD CITY
CA
94065
1
0
0
0
0
Voting Common Stock
2023-11-16
4
P
0
10000
0.5965
A
10000
D
Voting Common Stock
2023-11-17
4
P
0
10000
0.5966
A
20000
D
Voting Common Stock
2023-11-20
4
P
0
10000
0.6309
A
30000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
By: /s/ Herb Cross, as Attorney-in-Fact
2023-11-20